US Patent 11214548 Cannabinoid receptor modulators
Patent 11214548 was granted and assigned to Arena Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11214548 Cannabinoid receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
